Impact of early dose intensity on cytogenetic and molecular responses in chronic- phase CML patients receiving 600 mg/day of imatinib as initial therapy (Q46392116)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Impact of early dose intensity on cytogenetic and molecular responses in chronic- phase CML patients receiving 600 mg/day of imatinib as initial therapy |
scientific article |
Statements
1 reference
Impact of early dose intensity on cytogenetic and molecular responses in chronic- phase CML patients receiving 600 mg/day of imatinib as initial therapy (English)
1 reference
1 reference
Timothy P Hughes
1 reference
Susan Branford
1 reference
John F Seymour
1 reference
Kerry Taylor
1 reference
Chris Arthur
1 reference
Anthony Schwarer
1 reference
James Morton
1 reference
Julian Cooney
1 reference
Michael F Leahy
1 reference
Philip Rowlings
1 reference
John Catalano
1 reference
Mark Hertzberg
1 reference
Robin Filshie
1 reference
Anthony K Mills
1 reference
Keith Fay
1 reference
Simon Durrant
1 reference
Henry Januszewicz
1 reference
David Joske
1 reference
Craig Underhill
1 reference
Scott Dunkley
1 reference
Kevin Lynch
1 reference
Andrew Grigg
1 reference
Australasian Leukaemia and Lymphoma Group
1 reference
3 September 2008
1 reference
1 reference
112
1 reference
3965-3973
1 reference
10
1 reference
Identifiers
1 reference
1 reference